Convalescent plasma treatment of hospitalized patients with COVID-19 has been subject to Emergency Use Authorization (EUA) since August of 2020. Subsequent scientific studies have indicated the need to modify this EUA by limiting use to immunocompromised patients. A...
HHSC recently became aware of an issue causing some claims for the administration of the MenQuadfi vaccine (procedure code 90619) to be denied inappropriately. MenQuadfi is approved by the U.S. Food and Drug Administration for individuals two years of age and older....
Effective for dates of service on or after March 29, 2022, in accordance with the U.S. Food and Drug Administration amendment to the Emergency Use Authorization, MCOs must add COVID-19 vaccine administration code 0094A for the administration of the booster dose of the...
Effective for dates of service on or after May 17, 2022, in accordance with the U.S. Food and Drug Administration (FDA) amendment to the Emergency Use Authorization (EUA), COVID-19 vaccine administration code 0074A is a benefit of Medicaid and CHIP for the...
Effective for dates of service on or after October 29, 2021, COVID-19 vaccine administrationadd-on procedure code M0201 is a benefit for clients 5 years of age or older for Texas Medicaidand CHIP. Procedure code M0201 is an add-on procedure code for use when a...
The Texas Medicaid & Healthcare Partnership’s (TMHP) Provider Enrollment and Management System (PEMS) is coming soon. PEMS Portal Effective December 13, 2021 Provider enrollment functions will be available through PEMS, and providers must usethe new system to...
